Incyte Corp (INCY)
$90.56
1.48 (1.61%)
19:39 EST
INCY Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
19.20B
PE Ratio
-119.16
EPS
-0.76
Volume (Avg. Vol.)
930,100
Day's Range
89.32 - 92.52
52-Week Range
62.48 - 110.36
Dividend & Yield
N/A (N/A)
INCY Stock Predictions, Articles, and Incyte Corp News
- From InvestorPlace
- From the Web
5 Big Biotech Stocks To Buy In 2018
Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today.
5 Stocks the Top Fund Managers Love
These top hedge fund stocks all have a 'very positive' confidence sentiment for the quarter and a 'Strong Buy' outlook from the Street.
Vapid Earnings Visibility Restrict Incyte (INCY) Rating
Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe.
5 Toxic Stocks to Abandon or Sell Short for Gains
Toxic stocks are susceptible to external shocks and are loaded with high amounts of debts. Also, the price of toxic stocks is irrationally high.
5 Toxic Stocks to Discard or Sell Short for Profit
Toxic stocks are exposed to outside shocks and are burdened with high levels of debts. Also, the price of toxic stocks is artificially inflated.
5 of the Toughest Stocks to Withstand a Downturn
These downturn-proof stocks to buy are much tougher than most on the market. Here's why each are among the toughest stocks to own.
5 Biotech Stocks That Are Breaking Higher
Biotech stocks are surging amid M&A speculation after Gilead agreed to buy Kite Pharma. And these biotechs are moving higher in response.
Incyte Corporation (INCY) Shares Drop on Q2 Loss
Incyte Corporation (INCY) shares fell following the pharmaceutical company's fiscal second-quarter results, which saw earnings disappoint.
Why Herbalife Ltd. (HLF), Snap Inc (SNAP) and Incyte Corporation (INCY) Are 3 of Today’s Worst Stocks
Incyte (INCY), Snap (SNAP) and Herbalife (HLF) shareholders should have made it a three-day weekend. Here's why.
Incyte Corporation (INCY) Stock Jumps on Promising Lung Cancer Drug
Incyte (INCY) stock was up on Thursday on promising results in Phase 1 and Phase 2 studies for one of its lung cancer drugs.
4 Biotech Stocks That Could Be Rocked and Rolled This Month
If you own any of these biotech stocks (or are thinking about it), mark these four dates on your calendar. Things are going to get real interesting, real fast.
Why Dish Network Corp (DISH), Snyder’s-Lance Inc (LNCE) and Incyte Corporation (INCY) Are 3 of Today’s Worst Stocks
Incyte (INCY), Dish Network (DISH) and Snyder's-Lance (LNCE) shareholders ended up wishing this past weekend was a four-day trading break.
Eli Lilly and Co (LLY) Stock Holders Choke on FDA Letter for Barictinib
Eli Lilly (LLY) took a hit Monday after an FDA letter on dosages and safety likely delayed Olumiant's U.S. market entry. But LLY stock still has its virtues.
The 10 Best Stocks of the S&P 500 in Q1
By
Jeff Reeves
While the markets have been performing well in general for the first quarter, some of the S&P 500's best stocks have really cut loose.
5 Top Stocks to Buy as Bull Market Turns Eight
We have selected 5 Buy-ranked stocks that have outperformed in the current bull market with room to run higher.
8 of the Most Overrated Stocks on Wall Street Right Now
Some stocks are graded fairly, but a handful of the most overrated stocks deserve to be called out -- and sold sooner than later.
5 Toxic Stocks to Dump or Play Short Now
Higher prices of toxic stocks can be attributed to irrational exuberance or serious fundamental lacuna. Here are 5 stocks to consider selling
37 Biotechnology Stocks to Sell Now
This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Services Stocks Now – VDSI SYNA EXAS INCY
The Services sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Services Stocks Now – CCIH TTGT MOC YY
The Services sector saw plenty of trading activity today, including the following leaders and losers.

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold